» Authors » Katherine Shin

Katherine Shin

Explore the profile of Katherine Shin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 387
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramaswamy V, Munz S, Nalliah R, Fitzgerald M, Dragan I, Karimbux N, et al.
J Dent Educ . 2021 Sep; 86(1):88-97. PMID: 34554573
Purpose/objectives: The aim of this study is to report data on the lack of a proper patient handoff system in dentistry and dental education and to present a possible solution...
2.
Landovitz R, Donnell D, Clement M, Hanscom B, Cottle L, Coelho L, et al.
N Engl J Med . 2021 Aug; 385(7):595-608. PMID: 34379922
Background: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. Methods: We conducted...
3.
Kadhium V, Shin K, Ramaswamy V, Nalliah R
J Dent Educ . 2021 Apr; 85 Suppl 3:2014-2015. PMID: 33860532
No abstract available.
4.
Gausi K, Wiesner L, Norman J, Wallis C, Onyango-Makumbi C, Chipato T, et al.
Clin Pharmacol Ther . 2020 Sep; 109(4):1034-1044. PMID: 32909316
The World Health Organization guidelines recommend that individuals living with HIV receive ≥ 6 months of isoniazid preventive therapy, including pregnant women. Yet, plasma isoniazid exposure during pregnancy, in the...
5.
Gupta A, Montepiedra G, Aaron L, Theron G, McCarthy K, Bradford S, et al.
N Engl J Med . 2019 Oct; 381(14):1333-1346. PMID: 31577875
Background: The safety, efficacy, and appropriate timing of isoniazid therapy to prevent tuberculosis in pregnant women with human immunodeficiency virus (HIV) infection who are receiving antiretroviral therapy are unknown. Methods:...
6.
Gupta S, Hakim M, Patel D, Stow L, Shin K, Timothe P, et al.
Dent J (Basel) . 2019 Aug; 7(3). PMID: 31374831
The Action for Dental Health Act of 2017 bill is intended to prevent dental disease and divert dental emergencies from high-cost centers (like hospital emergency rooms) to dental offices. Lines...
7.
Melvin A, Montepiedra G, Aaron L, Meyer 3rd W, Spiegel H, Borkowsky W, et al.
Pediatr Infect Dis J . 2016 Oct; 36(1):53-60. PMID: 27749649
Background: Human immunodeficiency virus (HIV)-infected children receiving antiretroviral therapy (ART) have increased prevalence of hyperlipidemia and risk factors for cardiovascular disease. No studies have investigated the efficacy and safety of...
8.
Metzger D, Donnell D, Celentano D, Jackson J, Shao Y, Aramrattana A, et al.
J Acquir Immune Defic Syndr . 2015 Jan; 68(5):554-61. PMID: 25564105
Background: Injection opioid use plays a significant role in the transmission of HIV infection in many communities and several regions of the world. Access to evidence-based treatments for opioid use...